🔎 Trials Near Me

Utama › Tumor Otak › Utah

Kajian klinikal Tumor Otak di Utah

8 kajian untuk Tumor Otak sedang mencari peserta di lokasi di Utah.

Bandar di Utah

Teks kajian rasmi (Bahasa Inggeris)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04511013

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • Primary Children's Hospital, Salt Lake City
Mengambil pesertaFasa 2
59 Months · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05535166

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • START Mountain Region, West Valley City
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06253871

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

  • Huntsman Cancer Institute, Salt Lake City
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT02390518

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • University of Utah, Huntsman Cancer Institute, Salt Lake City
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06810544

Guided Meditation During Radiation Therapy for Brain Tumors

  • Huntsman Cancer Institute, Salt Lake City
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT06165653

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

  • Huntsman Cancer Institute, Salt Lake City
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Dis 2025 · NCT06194929

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.